(NASDAQ: GLTO) Galecto's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 5.47%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 15.21%.
Galecto's earnings in 2025 is -$16,594,000.On average, 1 Wall Street analyst forecast GLTO's earnings for 2025 to be -$14,636,388, with the lowest GLTO earnings forecast at -$14,636,388, and the highest GLTO earnings forecast at -$14,636,388. On average, 1 Wall Street analyst forecast GLTO's earnings for 2026 to be -$3,894,206, with the lowest GLTO earnings forecast at -$3,894,206, and the highest GLTO earnings forecast at -$3,894,206.
In 2027, GLTO is forecast to generate -$3,258,418 in earnings, with the lowest earnings forecast at -$3,258,418 and the highest earnings forecast at -$3,258,418.